Elite Pharmaceuticals CFO Robert Chen resigns; search underway for replacement

ELITE PHARMACEUTICALS INC /NV/

CFO Robert Chen notified intent to resign on February 25, 2023.
Chen also served as Treasurer and Secretary; all roles vacated.
Company has commenced a search for a successor; no interim named.
Nasrat Hakim remains President and CEO during the transition.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robert Chen

Chief Financial Officer, Treasurer and Secretary

ELTP · ELITE PHARMACEUTICALS INC /NV/

Filed: February 28, 2023, 6:59 PM ET

On February 25, 2023, Robert Chen notified Elite Pharmaceuticals, Inc. (the “Company”) of his intent to leave the Company and resign from his position as Chief Financial Officer, Treasurer and Secretary.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Robert Chen resigned as Chief Financial Officer, Treasurer and Secretary at ELITE PHARMACEUTICALS INC /NV/.

Action: resigned
Role: Chief Financial Officer, Treasurer and Secretary

Exact text from the filing

On February 25, 2023, Robert Chen notified Elite Pharmaceuticals, Inc. (the “Company”) of his intent to leave the Company and resign from his position as Chief Financial Officer, Treasurer and Secretary.

View on SEC.gov

ELITE PHARMACEUTICALS INC /NV/ filing history →

Source: SEC EDGAR

accession 0001493152-23-006270

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.